Cynergy: the CYPHER-NEVO Registry (CYNERGY)
Cynergy - The CYPHER-NEVO Registry. An Observational Registry, to Evaluate the Safety and Performance of the NEVO™ Sirolimus-eluting Coronary Stent in Routine Clinical Practice, and to Compare Its Safety and Performance With the CYPHER Select® Plus Sirolimus-eluting Coronary Stent (SES)
Sponsor: Cordis US Corp.
Terminated
Early termination of patient enrollment based on business decision
Other terminated trials from Cordis US Corp.
- Coronary Artery Disease Aggravated · Nov 2020
- Atherosclerotic Coronary Artery Disease · Phase PHASE3 · Oct 2012
- Coronary Artery Disease · Phase PHASE4 · Sep 2008
- Arterial Occlusive Diseases · Phase PHASE4 · Jun 2008
- Peripheral Vascular Diseases · Phase PHASE1/PHASE2 · May 2004
More terminations from Cordis US Corp.
Other Coronary Artery Disease trials with similar outcome
Listed as NCT01106378, this observational or N/A phase trial focuses on Coronary Artery Disease and remains terminated or withdrawn. Sponsored by Cordis US Corp., it has been updated 8 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Terminated
-
Sep 2025 — Dec 2025 [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cordis US Corp.
For direct contact, visit the study record on ClinicalTrials.gov .